The workgroup also highlighted encouraging real-world data supporting the validation of the IDEOM MSK-Q in psoriatic disease, as well as efforts to improve psoriatic arthritis (PsA) screening and management in dermatology clinics through EMR integration of the PEST and PsAID-12 to support evaluation, assess disease impact, and support timely rheumatology referral and treatment decisions
GLP-1s: Driving Changes in Buying Behavior 5.3% reduction in grocery spend 1 8% reduction in fast food, coffee chain and limited-service restaurant spend 2 10.1% reduction in savory snack spend 3 Up to 40% reduction in alcohol spend 4 In 2024, a leading consumer packaged goods company launched its first major U.S
Pazienti con diabete di tipo 2 (ATTAIN-2) Sempre a 72 settimane e alla dose massima da 17,2 mg, la perdita di peso media stata del 9,6% , contro il 2,5% del placebo, con una riduzione dellemoglobina glicata di circa 1,8 punti percentuali da un basale dell8,1% (Horn et al., 2025)
5.2 Tirzepatide (SURMOUNT Trials) Tirzepatide demonstrated even greater mean weight loss in SURMOUNT trials. Findings included: Weight reductions exceeding 20% in some cohorts Dose-dependent gastrointestinal symptoms Lean mass reduction proportional to total weight loss Again, detailed micronutrient panels were not central trial endpoints
Our general counsel signs off on all closed-door topics and sits in on all closed-door sessions to ensure we stay within the confines of the law, Leonardi told the Sun Sentinel
